Searched for: school:SOM
Department/Unit:Neurology
Proteomic differences in the hippocampus and cortex of epilepsy brain tissue
Pires, Geoffrey; Leitner, Dominique; Drummond, Eleanor; Kanshin, Evgeny; Nayak, Shruti; Askenazi, Manor; Faustin, Arline; Friedman, Daniel; Debure, Ludovic; Ueberheide, Beatrix; Wisniewski, Thomas; Devinsky, Orrin
Epilepsy is a common neurological disorder affecting over 70 million people worldwide, with a high rate of pharmaco-resistance, diverse comorbidities including progressive cognitive and behavioural disorders, and increased mortality from direct (e.g. sudden unexpected death in epilepsy, accidents, drowning) or indirect effects of seizures and therapies. Extensive research with animal models and human studies provides limited insights into the mechanisms underlying seizures and epileptogenesis, and these have not translated into significant reductions in pharmaco-resistance, morbidities or mortality. To help define changes in molecular signalling networks associated with seizures in epilepsy with a broad range of aetiologies, we examined the proteome of brain samples from epilepsy and control cases. Label-free quantitative mass spectrometry was performed on the hippocampal cornu ammonis 1-3 region (CA1-3), frontal cortex and dentate gyrus microdissected from epilepsy and control cases (n = 14/group). Epilepsy cases had significant differences in the expression of 777 proteins in the hippocampal CA1 - 3 region, 296 proteins in the frontal cortex and 49 proteins in the dentate gyrus in comparison to control cases. Network analysis showed that proteins involved in protein synthesis, mitochondrial function, G-protein signalling and synaptic plasticity were particularly altered in epilepsy. While protein differences were most pronounced in the hippocampus, similar changes were observed in other brain regions indicating broad proteomic abnormalities in epilepsy. Among the most significantly altered proteins, G-protein subunit beta 1 (GNB1) was one of the most significantly decreased proteins in epilepsy in all regions studied, highlighting the importance of G-protein subunit signalling and G-protein-coupled receptors in epilepsy. Our results provide insights into common molecular mechanisms underlying epilepsy across various aetiologies, which may allow for novel targeted therapeutic strategies.
PMCID:8214864
PMID: 34159317
ISSN: 2632-1297
CID: 5387022
Race/Ethnic Disparities Publications in Neurological Journals During an Era of Heightened Awareness to Issues of Diversity, Equity and Inclusion [Meeting Abstract]
Esenwa, Charles; Patel, Nikunj; Wallace, Emma; Etienne, Mill; Ovbiagele, Bruce
ISI:000704705300197
ISSN: 0364-5134
CID: 5261372
Impact of COVID-19 on the hospitalization, treatment, and outcomes of intracerebral and subarachnoid hemorrhage in the United States
Ravindra, Vijay M; Grandhi, Ramesh; Delic, Alen; Hohmann, Samuel; Shippey, Ernie; Tirschwell, David; Frontera, Jennifer A; Yaghi, Shadi; Majersik, Jennifer J; Anadani, Mohammad; de Havenon, Adam
OBJECTIVE:To examine the outcomes of adult patients with spontaneous intracranial and subarachnoid hemorrhage diagnosed with comorbid COVID-19 infection in a large, geographically diverse cohort. METHODS:We performed a retrospective analysis using the Vizient Clinical Data Base. We separately compared two cohorts of patients with COVID-19 admitted April 1-October 31, 2020-patients with intracerebral hemorrhage (ICH) and those with subarachnoid hemorrhage (SAH)-with control patients with ICH or SAH who did not have COVID-19 admitted at the same hospitals in 2019. The primary outcome was in-hospital death. Favorable discharge and length of hospital and intensive-care stay were the secondary outcomes. We fit multivariate mixed-effects logistic regression models to our outcomes. RESULTS:There were 559 ICH-COVID patients and 23,378 ICH controls from 194 hospitals. In the ICH-COVID cohort versus controls, there was a significantly higher proportion of Hispanic patients (24.5% vs. 8.9%), Black patients (23.3% vs. 20.9%), nonsmokers (11.5% vs. 3.2%), obesity (31.3% vs. 13.5%), and diabetes (43.4% vs. 28.5%), and patients had a longer hospital stay (21.6 vs. 10.5 days), a longer intensive-care stay (16.5 vs. 6.0 days), and a higher in-hospital death rate (46.5% vs. 18.0%). Patients with ICH-COVID had an adjusted odds ratio (aOR) of 2.43 [1.96-3.00] for the outcome of death and an aOR of 0.55 [0.44-0.68] for favorable discharge. There were 212 SAH-COVID patients and 5,029 controls from 119 hospitals. The hospital (26.9 vs. 13.4 days) and intensive-care (21.9 vs. 9.6 days) length of stays and in-hospital death rate (42.9% vs. 14.8%) were higher in the SAH-COVID cohort compared with controls. Patients with SAH-COVID had an aOR of 1.81 [1.26-2.59] for an outcome of death and an aOR of 0.54 [0.37-0.78] for favorable discharge. CONCLUSIONS:Patients with spontaneous ICH or SAH and comorbid COVID infection were more likely to be a racial or ethnic minority, diabetic, and obese and to have higher rates of death and longer hospital length of stay when compared with controls.
PMCID:8046225
PMID: 33852591
ISSN: 1932-6203
CID: 4846102
A whole-cortex probabilistic diffusion tractography connectome
Rosen, Burke Q; Halgren, Eric
The WU-Minn Human Connectome Project (HCP) is a publicly-available dataset containing state-of-art structural, functional, and diffusion-MRI for over a thousand healthy subjects. While the planned scope of the HCP included an anatomical connectome, resting-state functional-MRI forms the bulk of the HCP's current connectomic output. We address this by presenting a full-cortex connectome derived from probabilistic diffusion tractography and organized into the HCP-MMP1.0 atlas. Probabilistic methods and large sample sizes are preferable for whole-connectome mapping as they increase the fidelity of traced low-probability connections. We find that overall, connection strengths are lognormally distributed and decay exponentially with tract length, that connectivity reasonably matches macaque histological tracing in homologous areas, that contralateral homologs and left-lateralized language areas are hyperconnected, and that hierarchical similarity influences connectivity. We compare the diffusion-MRI connectome to existing resting-state fMRI and cortico-cortico evoked potential connectivity matrices and find that it is more similar to the latter. This work helps fulfill the promise of the HCP and will make possible comparisons between the underlying structural connectome and functional connectomes of various modalities, brain states, and clinical conditions.Significance Statement The tracts between cortical parcels can be estimated from diffusion MRI, but most studies concentrate on only the largest connections. Here we present an atlas, the largest and most detailed of its kind, showing connections among all cortical parcels. Connectivity is relatively enhanced between frontotemporal language areas and homologous contralateral locations. We find that connectivity decays with fiber tract distance more slowly than predicted by brain volume and that structural and stimulation-derived connectivity are more similar to each other than to resting-state functional MRI correlations. The connectome presented is publicly available and organized into a commonly used scheme for defining brain areas in order to enable ready comparison to other brain imaging datasets of various modalities.
PMID: 33483325
ISSN: 2373-2822
CID: 4766622
Interactive Associations of Neuropsychiatry Inventory-Questionnaire Assessed Sleep Disturbance and Vascular Risk on Alzheimer's Disease Stage Progression in Clinically Normal Older Adults
Bubu, Omonigho M; Williams, Ellita T; Umasabor-Bubu, Ogie Q; Kaur, Sonya S; Turner, Arlener D; Blanc, Judite; Cejudo, Jaime Ramos; Mullins, Anna E; Parekh, Ankit; Kam, Korey; Osakwe, Zainab T; Nguyen, Ann W; Trammell, Antoine R; Mbah, Alfred K; de Leon, Mony; Rapoport, David M; Ayappa, Indu; Ogedegbe, Gbenga; Jean-Louis, Girardin; Masurkar, Arjun V; Varga, Andrew W; Osorio, Ricardo S
PMCID:8704133
PMID: 34955813
ISSN: 1663-4365
CID: 5089082
The Neutrophil to Lymphocyte Ratio Is Associated With the Risk of Subsequent Dementia in the Framingham Heart Study
Ramos-Cejudo, Jaime; Johnson, Andrew D; Beiser, Alexa; Seshadri, Sudha; Salinas, Joel; Berger, Jeffrey S; Fillmore, Nathanael R; Do, Nhan; Zheng, Chunlei; Kovbasyuk, Zanetta; Ardekani, Babak A; Bubu, Omonigho M; Parekh, Ankit; Convit, Antonio; Betensky, Rebecca A; Wisniewski, Thomas M; Osorio, Ricardo S
PMCID:8670436
PMID: 34916927
ISSN: 1663-4365
CID: 5080232
Neurodegeneration Over 3 Years Following Ischaemic Stroke: Findings From the Cognition and Neocortical Volume After Stroke Study
Brodtmann, Amy; Werden, Emilio; Khlif, Mohamed Salah; Bird, Laura J; Egorova, Natalia; Veldsman, Michele; Pardoe, Heath; Jackson, Graeme; Bradshaw, Jennifer; Darby, David; Cumming, Toby; Churilov, Leonid; Donnan, Geoffrey
PMCID:8570373
PMID: 34744989
ISSN: 1664-2295
CID: 5050152
Prevalence and Predictors of Prolonged Cognitive and Psychological Symptoms Following COVID-19 in the United States
Frontera, Jennifer A; Lewis, Ariane; Melmed, Kara; Lin, Jessica; Kondziella, Daniel; Helbok, Raimund; Yaghi, Shadi; Meropol, Sharon; Wisniewski, Thomas; Balcer, Laura; Galetta, Steven L
Background/Objectives/UNASSIGNED:Little is known regarding the prevalence and predictors of prolonged cognitive and psychological symptoms of COVID-19 among community-dwellers. We aimed to quantitatively measure self-reported metrics of fatigue, cognitive dysfunction, anxiety, depression, and sleep and identify factors associated with these metrics among United States residents with or without COVID-19. Methods/UNASSIGNED:We solicited 1000 adult United States residents for an online survey conducted February 3-5, 2021 utilizing a commercial crowdsourcing community research platform. The platform curates eligible participants to approximate United States demographics by age, sex, and race proportions. COVID-19 was diagnosed by laboratory testing and/or by exposure to a known positive contact with subsequent typical symptoms. Prolonged COVID-19 was self-reported and coded for those with symptoms ≥ 1 month following initial diagnosis. The primary outcomes were NIH PROMIS/Neuro-QoL short-form T-scores for fatigue, cognitive dysfunction, anxiety, depression, and sleep compared among those with prolonged COVID-19 symptoms, COVID-19 without prolonged symptoms and COVID-19 negative subjects. Multivariable backwards step-wise logistic regression models were constructed to predict abnormal Neuro-QoL metrics. Results/UNASSIGNED:= 0.047), but there were no significant differences in quantitative measures of anxiety, depression, fatigue, or sleep. Conclusion/UNASSIGNED:Prolonged symptoms occurred in 25% of COVID-19 positive participants, and NeuroQoL cognitive dysfunction scores were significantly worse among COVID-19 positive subjects, even after accounting for demographic and stressor covariates. Fatigue, anxiety, depression, and sleep scores did not differ between COVID-19 positive and negative respondents.
PMCID:8326803
PMID: 34349633
ISSN: 1663-4365
CID: 5005972
An Interview-Based Assessment of the Experience of Cognitive Impairment in Multiple Sclerosis: The Cognitive Assessment Interview (CAI)
Eilam-Stock, Tehila; Best, Pamela; Sherman, Kathleen; Shaw, Michael T; Ventura, Joseph; Krupp, Lauren B; Charvet, Leigh E
Background: Cognitive impairment is a common feature of multiple sclerosis (MS). A semi-structured interview, including informant input, can characterize the experience of individuals living with MS and cognitive involvement. Objective: We administered the Cognitive Assessment Interview (CAI), a patient- and informant-based semi-structured interview, to characterize the experience of cognitive impairments in those living with MS. Methods: Trained raters administered the CAI to a sample of MS participants and their informants enrolled for a trial of cognitive remediation. Cognitive impairments on the CAI were characterized and compared to those captured by neuropsychological and self-report measures. Results: A total of n = 109 MS participants (mean age = 50.3 ± 12.2) and their available informants (n = 71) were interviewed. Participants reported experiencing processing speed (90/106, 85%), working memory (87/109, 80%), and learning and memory (79/109, 72%) problems most commonly. CAI-based ratings were moderately correlated with a self-report measure (Multiple Sclerosis Neuropsychological Screening Questionnaire, rs = 0.52, p < 0.001) and only mildly correlated with objective neuropsychological measures specific to executive functions (r
PMCID:7905222
PMID: 33643211
ISSN: 1664-2295
CID: 4801072
Developing mental health literacy and cultural competence in elite sport
Gorczynski,Paul; Currie,Alan; Gibson,Kass; Gouttebarge,Vincent; Hainline,Brian; Castaldelli-Maia,João Mauricio; Mountjoy,Margo; Purcell,Rosemary; Reardon,Claudia L.; Rice,Simon; Swartz,Leslie
Mental health symptoms and disorders amongst elite athletes have attracted a great deal of discussion recently. Current epidemiological evidence illustrates that mental health symptoms and disorders in elite athletes are prevalent and a concern for athletes, coaches, and sport organizations. Recently, seven consensus, expert, or position statements have been written on the topic of mental health in elite sport. A strategy suggested by each of the seven statements – aimed at preventing and treating mental health symptoms and disorders in elite athletes, both individually and systemically – is to employ education interventions, specifically those based on increasing mental health literacy. Mental health literacy has come to include concepts related to knowledge of effective self-management strategies, challenging mental disorder stigma, awareness and use of mental health first-aid to assist others, and the facilitation of help seeking behaviors. In elite sport, questions remain about how mental health literacy can address the unique needs of the individual athlete, but also factor in their culture and their environment to identify how to prevent and treat mental health symptoms and disorders. The purpose of this commentary is twofold: 1) to explore the evolving concept of mental health literacy within elite sport which addresses individuals, their culture, and their environment, and 2) to propose strategies for best practice and research in mental health literacy within elite sport relying on collaboration between sports psychiatry, sport psychology, and clinical psychology. Lay summary: Expert statements on mental health in elite sport have suggested the use of educational strategies to address poor mental health in elite athletes. This commentary explores the concept of mental health literacy within elite sport which addresses individuals, their culture, and their environment, and proposes strategies for best practice.Implications for PracticeMental health literacy interventions should be based on detailed knowledge of developmental, cultural, and social issues related to sport participation and systemic issues within sport settings and organizations.Mental health literacy interventions should be designed in a manner which takes due account of cultural issues and contexts, where sport organizational goals are considered while helping organizations recognize and address mental health symptoms and disorders and also create sport environments where individuals can thrive.Mental health literacy interventions should have measurable impact on both organizations and individuals. Mental health literacy interventions should be based on detailed knowledge of developmental, cultural, and social issues related to sport participation and systemic issues within sport settings and organizations. Mental health literacy interventions should be designed in a manner which takes due account of cultural issues and contexts, where sport organizational goals are considered while helping organizations recognize and address mental health symptoms and disorders and also create sport environments where individuals can thrive. Mental health literacy interventions should have measurable impact on both organizations and individuals.
ORIGINAL:0017524
ISSN: 1041-3200
CID: 5775092